NETs inhibitors, including PAD4 inhibitors, NADPH oxidase inhibitors, and recombinant DNase I, have demonstrated anti-inflammatory, neuroprotective, and BBB preserving effects in various animal models of intracerebral hemorrhage. The gene discussed is DNASE1; the disease is intracerebral hemorrhage.